Novanta
- Market cap
- 5.43B
- P/E (TTM)i
- 90.91
- P/Bi
- 3.36
- EPSi
- 1.47
- Div yieldi
- 0.00%
- 52W posi
- 58%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Fair Value how this is computed
- Implied fair-value range of 101.02-149.59, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is +14.6% above the average-multiple fair value of 125.30.
Valuation each multiple against its own 5-year range
Vs. peers Scientific & Technical Instruments
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Novanta (NOVT) | 5.43B | 90.91 | 3.36 | 0.00% |
| Coherent (COHR) | 65.52B | 81.20 | 6.01 | 0.00% |
| Keysight Technologies (KEYS) | 64.93B | 52.39 | 9.88 | 0.00% |
| Garmin (GRMN) | 53.26B | 28.50 | 5.90 | 1.36% |
| Teledyne Technologies (TDY) | 28.01B | 29.23 | 2.56 | 0.00% |
| MKS Inc (MKSI) | 18.47B | 43.50 | 6.18 | 0.34% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 2.0% above Morningstar's fair value estimate.
Fair value
Novanta Inc receives a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 7% premium over our quantitative fair value estimate of $140.74 per share; however, this estimate should be taken with a pinch of salt due to its medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.
The company's valuation metrics decrease our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 28.7%, which sits in the bottom 30% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are expensive.
The company's lack of profitability is an additional cause for concern. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 1.9%, a core component of profitability, falls in the bottom 40% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which further promotes our unfavorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.
Economic moat
The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-10-08 06:25:34 · For reference only, not investment advice and not tailored to your situation.